Oncologic centers participating in this study
Institution . | Number of submitted cases . |
---|---|
Karolinska Hospital, Stockholm, Sweden | 20 |
The Swedish National Care Group, Uppsala | 46 |
University Central Hospital, Helsinki, Finland | 48 |
University Hospital Copenhagen, Denmark | 30 |
St. Bartholomew's Hospital, London, England | 26 |
Royal Victoria Infirmary, Newcastle upon Tyne, England | 40 |
Christie Hospital, Manchester, England | 97 |
General Hospital “Gregorio Marañón” Madrid, Spain | 8 |
Institut Bergonié, Bordeaux, France | 11 |
Éduard Herriot Hospital, Lyon, France | 2 |
Leiden Medical Center, Leiden, The Netherlands | 33 |
The German Hodgkin Study Group | 50 |
National Institute for Study and Treatment of Cancer, Milano, Italy | 38 |
“La Sapienza” University, Rome, Italy | 8 |
M. D. Anderson Cancer Center, Houston, TX | 21 |
Mayo Clinic, Rochester, MN | 43 |
Institution . | Number of submitted cases . |
---|---|
Karolinska Hospital, Stockholm, Sweden | 20 |
The Swedish National Care Group, Uppsala | 46 |
University Central Hospital, Helsinki, Finland | 48 |
University Hospital Copenhagen, Denmark | 30 |
St. Bartholomew's Hospital, London, England | 26 |
Royal Victoria Infirmary, Newcastle upon Tyne, England | 40 |
Christie Hospital, Manchester, England | 97 |
General Hospital “Gregorio Marañón” Madrid, Spain | 8 |
Institut Bergonié, Bordeaux, France | 11 |
Éduard Herriot Hospital, Lyon, France | 2 |
Leiden Medical Center, Leiden, The Netherlands | 33 |
The German Hodgkin Study Group | 50 |
National Institute for Study and Treatment of Cancer, Milano, Italy | 38 |
“La Sapienza” University, Rome, Italy | 8 |
M. D. Anderson Cancer Center, Houston, TX | 21 |
Mayo Clinic, Rochester, MN | 43 |